Genenta Science SpA ADR (GNTA) Financials

$0.83

$-0.01 (-1.76%)

As on 14-Sep-2026 12:36EDT

Market cap

$41 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.6

Div. Yield

0 %

Annual
Quarterly

Income Statement (€ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.03	0.05	0.04	0.01	0.01	0.00
Gross Profit	-0.03	-0.05	-0.04	-0.01	-0.01	0.00
Operating Expenses	6.32	10.15	11.48	10.78	5.92	5.20
Operating Profit (EBIT)	-6.34	-10.20	-11.53	-10.79	-5.93	-5.20
Other Income	--	--	--	--	--	--
Profit before Tax	-6.27	-9.31	-11.44	-8.28	-5.76	-5.20
Provision for Tax	--	--	0.00	-4.85	0.03	0.01
Profit after Tax (Net Income)	-6.27	-9.31	-11.44	-8.28	-5.76	-5.20
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-5.59

Liabilities (€ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	21.84	12.50	20.43	31.14	38.86	15.15
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	7.93	0.23	0.18	0.12	0.03	0.02
Current Liabilities	2.12	2.10	1.74	2.18	1.14	2.33
Total Liabilities	31.89	14.82	22.35	33.44	40.03	17.50

Assets (€ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	1.91	0.35	1.09	1.72	1.27	0.97
Current Assets	29.98	14.47	21.26	31.72	38.76	16.53
Total Assets	31.89	14.82	22.35	33.44	40.03	17.50
Total Debt*	7.60	0.01	0.00	--	--	--
Net Current Assets	27.86	12.37	19.52	29.54	37.62	14.20

Cashflow (€ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	-6.87	-6.24	-11.21	-7.42	-6.96	-6.04
Cash Flow from Investing Activities	-14.54	6.88	-14.89	-0.03	-0.01	-0.02
Cash from Financing Activities	22.29	0.27	0.00	--	28.74	1.39
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS (€)	-0.33	-0.51	-0.63	-0.45	-0.32	-0.35
Cash EPS (€)	-0.33	-0.51	-0.63	-0.45	-0.32	-0.35
Adjusted Book Value (€)	1.16	0.68	1.12	1.71	2.13	1.03
Dividend per Share (€)	--	--	--	--	--	--
Cash Flow per Share (€)	-0.37	-0.34	-0.62	-0.41	-0.38	-0.41
Free Cash Flow per Share (€)	-0.37	-0.34	-0.62	-0.41	-0.38	-0.41

Profitability Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	-29.90	-56.52	-44.37	-23.66	-21.34	-30.61
ROE (%)	-36.53	-56.55	-44.37	-23.66	-21.34	-30.61
ROA (%)	-26.85	-50.09	-41.02	-22.54	-20.04	-26.79
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	36.76	18.62	-38.18	-43.64	-10.81	-12.49
Net Profit Growth (%)	32.63	18.62	-38.18	-43.64	-10.77	-14.81
EPS Growth (%)	0.34	0.19	-0.38	-0.44	0.11	-0.42
Book Value Growth (%)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	0.35	0.00	0.00	--	--	--
Short term debt to equity ratio	--	0.00	--	--	--	--
Current Ratio	14.16	6.89	12.25	14.53	34.15	7.09
Quick Ratio	--	--	12.25	14.46	34.08	7.07
Interest Coverage	-15.32	--	--	-3.23	-491.99	-670.86

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	0.02	633.60	6,729.50	3,724.42	-14,029.48
Payable days	12,370.65	2,406.33	6,520.36	42,150.80	26,694.25	116,460.11
Cash Conversion Cycle	--	--	--	--	--	--